Fresenius Medical Care AG & Co KGaA ADR Stock
The price for the Fresenius Medical Care AG & Co KGaA ADR stock decreased slightly today. Compared to yesterday there is a change of -€0.100 (-0.520%).
Pros and Cons of Fresenius Medical Care AG & Co KGaA ADR in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Fresenius Medical Care AG & Co KGaA ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Fresenius Medical Care AG & Co KGaA ADR | -0.520% | -2.538% | -2.538% | -8.571% | -3.518% | -7.692% | -38.854% |
| Fresenius SE & Co. KGaA ADR | 0.000% | -0.926% | -5.310% | 10.881% | -9.322% | 67.188% | 12.042% |
| Carl Zeiss Meditec AG | -0.140% | 6.365% | 17.343% | -50.946% | -30.615% | -78.028% | -81.116% |
| Fresenius Medical Care AG & Co KGaA ST | 2.160% | -1.240% | -1.044% | -4.829% | -2.331% | -4.555% | -37.228% |
Comments
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
Show more
Ratings data for FMS provided by MarketBeat
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for FMS provided by MarketBeat
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) was downgraded by analysts at UBS Group AG from a "sell" rating to an "underperform" rating.
Show more
Ratings data for FMS provided by MarketBeat